Call for Abstract

International Conference on Carcinoma and Adenocarcinoma, will be organized around the theme “The Need to Individualize Advanced Carcinoma Care”

Carcinoma-2016 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Carcinoma-2016

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Cancer genomics and system biology
  • Track 1-2Damage to DNA cell
  • Track 1-3Tumor micro environment and immune therapy
  • Track 1-4Cancer stem cells
  • Track 1-5Environmental factors
  • Track 1-6History and physical examination
  • Track 1-7Dermascopy
  • Track 1-8Skin biopsy
  • Track 2-1Brain, bladder, breast, blood, oral, throat cancer
  • Track 2-2Cervical, colorectal, oesophageal cancer
  • Track 2-3Lung, ovarian, pancreatic, prostate cancer
  • Track 2-4Multiple, mylenoma, skin cancer
  • Track 2-5Advances in Cancer Genetics
  • Track 3-1Basal cell carcinoma
  • Track 3-2Squamous cell carcinoma
  • Track 3-3Adenocarcinoma
  • Track 3-4Anaplastic carcinoma
  • Track 3-5Adenosquamous carcinoma
  • Track 3-6Bronchial carcinoma
  • Track 3-7Oat cell carcinoma
  • Track 3-8Lung carcinoma
  • Track 4-1Bowen’s disease
  • Track 4-2Bump or lump on the skin
  • Track 4-3Kaposi sarcoma
  • Track 4-4Merkel cell carcinoma
  • Track 4-5Sebaceous gland carcinoma
  • Track 5-1Surgery
  • Track 5-2Chemotherapy
  • Track 5-3Radiation
  • Track 5-4Immunotherapy like sipuleucel-T
  • Track 5-5Cryrotherapy
  • Track 5-6Cow’s urine therapy
  • Track 5-7Retro-viral mediated gene therapy
  • Track 5-8Oncolytic virotherapy
  • Track 5-9Cervical cancer vaccine
  • Track 5-10HPV vaccination
  • Track 6-1ChromograninA (Cg A)
  • Track 6-2HER 2/ NEU Test
  • Track 6-3Cancer gene mutation testing
  • Track 6-4Tumor marker tests
  • Track 7-1Biological and external factors for carcinogenesis
  • Track 7-2Cancer research: clinical and experimental carcinomas
  • Track 7-3Metabolism of carcinogens
  • Track 7-4Anti-carcinogens
  • Track 8-1Basic skin cancer research
  • Track 8-2Preventing genital skin cancers
  • Track 8-3Chemoprevention
  • Track 8-4Anti-angiogenesis research
  • Track 8-5Vaccine research
  • Track 8-6Genetic research
  • Track 9-1Cancer microenvironment
  • Track 9-2Stealth nanoparticles and penetrating peptides
  • Track 9-3New nanomaterial
  • Track 9-4Early diagnosis and imaging
  • Track 9-5Advances in nanotechnology
  • Track 10-1Personalised genomics and clinical biomarkers
  • Track 10-2Biomarkers in cancer therapy and molecular diagnostics
  • Track 10-3Biomarkers in cancer detection
  • Track 10-4Targeting protein involving DNA
  • Track 10-5Metabolomics in novel biomarker